Purpose Ischemia reperfusion injury (IRI) remains a significant cause of morbidity and mortality after lung transplantation. Early growth response-1 (EGR1) drives the expression of inflammatory mediators and has an important role in IRI. We hypothesized that the severe IRI caused by a long preservation induces a specific expression pattern of EGR1 and its target genes which would correlate with the lung graft function. Methods SD rat lungs were preserved at 4°C for 3 or 18 h, then transplanted and reperfused. Pulmonary grafts were evaluated for the blood gas oxygenation and pathological findings. The intra-graft mRNA levels of EGR1 and its downstream target genes were measured by real-time PCR. A Western blotting analysis of the EGR1 expression was used to validate the changes in the protein level. Results There was upregulation of EGR1, MIP-2 and PAI-1 when there was prolonged hypothermic preservation. The expression levels of MIP-2 and PAI-1 were observed to increase for up to 4 h in the 18 h preserved lungs. There were no differences in the expression levels of IL-1b and ICAM-1 between the lungs subjected to short and long periods of ischemia. Conclusions Our data showed that prolonged hypothermic graft preservation deteriorates the pulmonary graft function, which was associated with the induction of EGR1 and its downstream target genes, which may aggravate IRI following lung transplantation.
Introduction
Lung transplantation is considered to be the most effective therapeutic modality for a variety of end-stage pulmonary diseases. Despite refinements in lung preservation and improvements in surgical techniques and perioperative care, primary graft dysfunction (PGD) remains a significant cause of morbidity and mortality after lung transplantation. The incidence of PGD reported in recent studies has varied from 11 to 57 % [1] . PGD typically occurs within the first 72 h after transplantation, and is characterized by nonspecific alveolar damage, lung edema, and hypoxemia. The cause of PGD is likely multifactorial; in addition to the duration of ischemic time, brain death-related donor lung injury, infection, cardiopulmonary bypass, and especially ischemia-reperfusion injury (IRI) represent some of the possible etiologies [2] . A better understanding of the molecular mechanisms of IRI will help in the quest to develop novel therapies and strategies to prevent or treat injury related to lung transplantation.
The early growth response gene product (EGR1), a zinc finger transcription factor, belongs to a larger family of early response genes. The activation of EGR1 has been shown to recruit multiple target genes encompassing both inflammatory and coagulant pathways, including plasminogen activator inhibitor 1 (PAI-1), macrophage inflammatory protein-2 (MIP-2), interleukin-1b (IL-1b), and intercellular adhesion molecule 1 (ICAM-1) [3] [4] [5] [6] . The expression of EGR1 is markedly upregulated in the setting of hypoxia, and plays an important role in IRI [4] [5] [6] . Although the ischemic time is thought to influence the severity of IRI following lung transplantation, the effects of prolonged cold preservation on the changes in the expression levels of EGR1 and its target genes during reperfusion have not been investigated. We hypothesized that the severe IRI caused by a long preservation induces significant changes in the expression patterns of EGR1 and its target genes, which correlate with the lung graft function. The aim of this study was to examine the effects of prolonged cold ischemia, which leads to severe IRI during reperfusion, on the time course of changes in the transcription levels of EGR1 and its target genes, PAI-1, MIP-2, IL-1b, and ICAM-1.
Methods

Animals and grafting techniques
Sprague-Dawley rats weighing 270-350 g were obtained from Charles River Laboratories Japan Inc.
Animals were anaesthetized by inhalation of diethyl ether and intraperitoneal injection of thiopental. A tracheostomy was performed with a 14 gauge angiocatheter. The animals were ventilated with 100 % O 2 mixed with 1.0 % halothane at a tidal volume of 10 ml/kg and a rate of 70 breaths/min with 3 cm of H 2 O for the positive endrespiratory pressure using a small animal respirator (Harvard Rodent Ventilator Model 683). A median sternotomy and thymectomy were performed to expose the heart and lung block. To obtain systemic anti-coagulation, 1,000 U/kg of heparin was injected into the inferior vena cava. The inferior vena cava and left and right atrial appendages were then incised. A 14 gauge intravenous catheter was placed into the main pulmonary artery, and the lungs were flushed with 20 ml/rat of flushing solution (phosphate buffered extracellular solution) [7] at 4°C. The lungs were separated and prepared for preservation and transplantation. The left lung was then stored at 4°C for 3 h (3 I) or 18 h (18 I) until transplantation. Each group included 25 lungs.
The rat recipients were anesthetized, and a tracheostomy was placed for ventilation in the same manner as in the donor rat. A left thoracotomy was performed, and the left lung hilar structures were dissected free. The left pulmonary artery, vein, and bronchus were clamped. The lung graft was transplanted by anastomosing the pulmonary vein, artery, and bronchus using a cuff technique [8] . The clamps were removed from the bronchus, pulmonary vein, and pulmonary artery in that order. The transplanted lung was then reinflated and reperfused. After 15 (15R), 30 (30R), 60 (1hR) or 240 min (4hR) of reperfusion, the transplanted lungs were excised and dissected. Each group included five samples. The lung tissues were divided, with one lung portion frozen in liquid nitrogen and stored at -80°C, and the remaining portion fixed in 10 % formaldehyde for hematoxylin and eosin staining, and a histological analysis was performed. Blood samples were taken from the pulmonary vein for a blood gas analysis just prior to harvesting the pulmonary grafts.
Isolation of total RNA and reverse transcription Total RNA was isolated from frozen lung tissue using the TRIzol reagent (Invitrogen Corp., Carlsbad, CA, USA) according to the manufacturer's protocol. After isolation, genomic DNA was removed using a DNA-free Kit (Ambion Inc., Austin, TX, USA). Proteins were also extracted from the frozen lung tissue using the TRIzol reagent according to the manufacturer's protocol. The proteins were stored at -20°C until the analyses.
Reverse transcription (RT) was performed according to the manufacturer's instructions using the SuperScript III First Strand Synthesis System (Invitrogen Corp.). Briefly, 2.5 lg of total RNA was added to diethylpyrocarbonate (DEPC) water, 1.0 lL of oligo (dT) 20 primer (50 lM), and 1.0 lL of dNTP mix (10 mM each). The volume of DEPC water was adjusted to a total mixture volume of 10 lL. Samples were heated to 65°C for 5 min, then placed on ice for at least 1 min. RT reactions were performed with 2 lL of 10 9 RT buffer, 25 mM MgCl 2 , 0.1 M dithiothreitol, 1 lL of RNAse out, and 1 lL of transcriptase (SuperScript III). The samples were incubated at 50°C for 50 min, followed by heating at 85°C for 5 min to complete reverse transcription. Finally, RNase (RNase H) was added to each of the samples, bringing their final volume to 21 lL, and the samples were incubated at 37°C for 20 min. The RT products were diluted 20-fold and stored at -20°C.
Real-time PCR
The PCR primers and TaqMan probe (universal probe library, Roche Diagnostics Corp., Indianapolis, IN, USA) were designed with Probe Finder Software on the Roche Applied Science website. A LightCycler 1.5 instrument (Roche Diagnostics Corp., Indianapolis, IN, USA) was used with the following protocol: 1 lL of RT product previously diluted 20-fold was added to 14.4 lL water, 4.0 lL of 5 9 Light Cycler TaqMan master mix (Roche Diagnostics Corp.), 0.2 lL of forward primer and reverse primer (both primers were diluted to adjust the final concentration to 200 nM), and 0.2 lL of TaqMan Probe (universal probe library, Roche Diagnostics Corp.); the final mixture (20 lL) was brought to 95°C for 10 min and then cycled 40 times, followed by incubation at 40°C for 30 s. A cycle consisted of 95°C for 10 s, 60°C for 30 s, and 72°C for 1 s. b-Actin was used as an internal control. The data are presented as the mean fold-changes over the expression level of the normal lung.
Western blot analysis
To detect EGR1, the total proteins were extracted from frozen lung tissue samples using the TRIzol reagent (Invitrogen Corp.) according to the manufacturer's protocol. The protein concentration was determined using the Bio-Rad protein assay (Bio-Rad Laboratories Inc., Hercules, California, USA). Twenty micrograms of protein were loaded into each lane of a polyacrylamide gel (Super Sep 7.5 %, Wako Pure Chemical Industries, Ltd., Osaka, Japan). The gel was then electrophoresed with SDS-PAGE buffer, and proteins were transferred electrophoretically to PVDF membranes. Non-specific binding was blocked by incubation of the membranes with skim milk for 30 min at room temperature. The membranes were then incubated with either an anti-EGR1 (sc-189) or anti-Actin (sc-7210) antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). The membranes with the primary antibodies were incubated overnight at 4°C with shaking at a dilution of 1:1,000 for the anti-EGR1 antibody and 1:10,000 for the anti-Actin antibody.
The membranes were then washed thrice with PBS and incubated with a goat anti-rabbit IgG (sc-2030) secondary antibody (diluted 1:10,000 for EGR1 and 1:15,000 for Actin; Santa Cruz Biotechnology Inc.) for 1 h. The proteins were detected by an ECL chemiluminescent substrate (ECL Advanced Western Blotting Detection Kit, GE Healthcare, Piscataway, NJ, USA).
Statistical analysis
Comparisons of the gene expression data obtained from the real-time RT-PCR were analyzed using the LightCycler Relative Quantification Software program (Roche Diagnostics Corp.). The densitometry of the Western blot bands was measured with the Image J software program (National Institute of Mental Health, Bethesda, Maryland, USA). The analyses were performed using the StatView 5.0 software program (SAS Institute Inc., Cary, NC, USA) using the Mann-Whitney U test. P values B0.05 were considered to be statistically significant.
Results
Graft function
The blood gas analyses revealed that the pulmonary graft function, measured as the left pulmonary vein oxygenation, showed significantly higher oxygenation in lungs subjected to 3 h of cold preservation at each time point in comparison to lungs cold preserved for 18 h (mean ± SE mmHg; 18 h cold-preserved-lung, 66.7 ± 29.8 mmHg; 3 h cold-preserved-lung, 367.8 ± 157.9 mmHg, P \ 0.01; Fig. 1a) . H&E staining of reperfused lung tissues revealed marked pulmonary congestion and edema in the transplanted rat lungs following 18 h of preservation. The histological findings in the graft implanted after the 3 h preservation showed an almost normal appearance, which was similar to the sham group (Fig. 1b-d) .
Real-time RT-PCR
EGR1
Real-time PCR revealed that prolonged cold preservation induced more upregulation of EGR1 mRNA in the lung tissues after transplantation. After 15 min of reperfusion, the expression level of the mRNA encoding EGR1 had already increased (mean ± SE fold-change; 3 I0R, 1.19 ± 0.32; 3I15R, 6.7 ± 1.2, P \ 0.01; 18 I0R, 1.34 ± 0.36; 18 I15R, 7.2 ± 1.4, P \ 0.01; Fig. 2a) . The maximum levels of EGR1 transcription were observed after 1 h of reperfusion; at that time point, the EGR1 mRNA expression was significantly higher in 18 I1hR lungs than in 3 I1hR lungs (mean ± SE fold-change over control; 3 I1hR, 21.7 ± 6.9; 18 I1hR, 77.4 ± 26.1, P = 0.03; Fig. 2a) . After 4 h of reperfusion, the EGR1 mRNA expression was significantly decreased compared to that 1 h after reperfusion, and no difference was observed between the groups.
Expression of the EGR1 target genes, PAI-1 and MIP-2
The expression patterns of the EGR1 target genes, PAI-1 and MIP-2, differed from those of EGR1, but they were strongly associated with the severity of IRI caused by prolonged cold ischemia during lung transplantation (Fig. 3a-d) . Although the expression levels of both PAI-1 and MIP2 mRNA were significantly reduced to 20 % of the levels in the control group at the end of cold preservation, they were dramatically upregulated upon the initiation of reperfusion and kept increasing for more than 4 h. Prolonged cold preservation led to a larger increase in the expression levels of the mRNA transcripts encoding PAI-1 Fig. 2 The effects of prolonged cold preservation followed by reperfusion on the EGR1 mRNA and protein expression levels in the transplanted lungs. Lung samples were collected from naive rats (normal; n = 5) or were preserved for 3 h (3 I) or 18 h (18 I) at 4°C, then were transplanted, and reperfused for the indicated duration of time (n = 5 for each time point). a The EGR1 mRNA levels observed by real-time PCR. The calculated data are expressed as the EGR1/bactin mRNA levels relative to those in normal lungs. b A Western blot analysis for EGR1 was performed. Actin was used as a control. The quantitative densitometric data (expressed as EGR1/actin levels relative to those in normal lung) from multiple experiments are shown as the mean ± SE Fig. 1 The pulmonary graft function. a The lung graft function as measured by the left pulmonary vein oxygenation. b H&E staining was performed on lung tissue specimens from rats without transplantation. Representative H&E staining in the lung after 1 h of reperfusion following 3 h cold preservation (c) and 18 h cold preservation (d) (mean ± SE fold-change over control; 3 I4hR, 30.1 ± 14.0; 18 I4hR, 91.0 ± 1.98, P \ 0.01) and MIP-2 (mean ± SE fold-change over control; 3 I4hR, 117.9 ± 50.0; 18 I4hR, 450.8 ± 202.0, NS).
Changes in the expression of ICAM-1 and IL-1b
No significant change in ICAM-1 mRNA expression was observed at any of the time points studied. The IL-1b mRNA expression was significantly increased at 1 h after reperfusion (mean ± SE fold-change over control; 3 I0R and 18 I0R, 0.57 ± 0.06, and 0.69 ± 0.06; 3 I1hR and 18 I1hR, 7.29 ± 0.72 and 6.55 ± 1.21, P \ 0.01). Prolonged cold preservation did not significantly affect the expression levels of IL-1b mRNA.
Western blot analysis
A Western blot analysis for EGR1 was performed to validate the changes in the protein levels of EGR1. We detected higher levels of EGR1 protein in transplanted lungs compared with normal lungs. We also observed a rapid increase in the EGR1 protein along a similar time course as the changes in the transcript level (Fig. 2b) .
Discussion
Hypothermic preservation is unavoidable to preserve the graft's function in the clinical situation of organ transplantation. IRI, a significant complication after lung transplantation, seems to be aggravated when the ischemic time is increased through prolonged hypothermic preservation [2] .
The activity of EGR1 is initially induced by environmental stimuli characteristically associated with injury and stress, including ischemia-reperfusion, through the Smad or non-Smad signaling pathways (e.g. the MAP kinase pathway). EGR1 induction triggers several downstream mechanisms leading to thrombosis, coagulation, inflammation, and leukocyte accumulation. Target gene promoters have functional EGR1 DNA-binding motifs, which allow for direct induction of the gene by EGR1. Recent studies have described that EGR1 induced a number of genes that participate in the physiological response to various kinds of stress, including PAI-1, IL1-b, MIP-2, and ICAM-1 [3] [4] [5] . The expression of these genes provides a mechanism to stimulate the coagulant and inflammatory pathways, potentially resulting in IRI after lung transplantation. Fig. 3 The effects of the duration of ischemia/ reperfusion on the mRNA levels of EGR1 target genes in the transplanted lungs. The time course of the changes in the transcription levels of the target genes of EGR1 was evaluated.
We herein investigated the impact of prolonged cold preservation on the expression levels of EGR1 and the target genes PAI-1, IL1-b, MIP-2, and ICAM-1 using an orthotopic lung transplantation model. Various time points were employed to measure the expression levels of these genes over time. These results might help to delineate the molecular mechanisms of IRI following transplantation.
In the current study, cold preservation itself did not affect the transcription levels of EGR1. However, subsequent transplantation and reperfusion induced a dramatic upregulation of EGR1 mRNA. Corresponding changes in the protein level were also observed. This upregulation was more pronounced under the condition of prolonged hypothermic preservation (18 h). Although the EGR1 transcription decreased by 4 h after beginning reperfusion, in severely injured grafts, the expression levels of MIP-2 and PAI-1 were observed to continue increasing for up to 4 h. No increase in the mRNA level of ICAM-1 was observed in either short-or long-term cold preservation grafts, even after transplantation. Conversely, the level of ICAM-1 mRNA was reduced during cold preservation prior to transplantation. Although a strong induction of the IL-1b transcript was observed after 1 h of reperfusion, there were no differences in the expression levels between lungs subjected to short-and long-term cold ischemia, despite the differences in graft function.
Recent studies have confirmed that IRI is a result of the upregulation of inflammatory mediators after reperfusion [2, 5, 9, 10] . In particular, IL-8 seems to play an important role in this respect, because it is released early after reperfusion and has been reported to predict graft function after human lung transplantation [11] . Indeed, we found that MIP-2 mRNA, homologous to human IL-8, was strongly induced during reperfusion in severely injured lungs subjected to prolonged cold ischemia, compared with low-level induction observed in well-functioning grafts. As coagulant factors have also been demonstrated to play an important role in pulmonary IRI in an experimental transplantation model [4] , our findings suggest that PAI-1 also plays a deleterious role in severe IRI caused by prolonged cold ischemia.
IL-1b and ICAM-1 are also recognized as important mediators of IRI complications after transplantation [3, 4] . Therefore, it was unexpected that we did not find a significant correlation between the intra-graft gene expression levels of these factors and the severity of IRI in the present study. The induction of IL-1b was observed even in the lungs subjected to short-term cold ischemia, suggesting that the upregulation of IL-1b in the transplanted lung is relatively independent of the graft function. It has been well established that the local production of cytokines supports the inflammatory response by increasing the expression of adhesion molecules and the direct recruitment of neutrophils. Some studies have reported that adhesion molecule expression levels were tightly correlated with the graft function after transplantation [3, 12] . However, the mRNA expression of ICAM-1 was clearly decreased in preserved lungs, and was not upregulated after transplantation or reperfusion. Possible explanations for this paradox might be the degradation of important intermediates, or the fact that mRNA upregulation is unnecessary when the expression of adhesion molecules increases on the cell surface.
If reliable biomarkers for graft function/dysfunction can be identified, they may provide insight into the pathogenesis of IRI, as well as prognostic value in predicting the natural history of patients with severe IRI. Recent clinical studies describing potential markers to predict IRI included the levels of cytokines such as IL-8 [11] and IL-6/IL-10 [13] , indicators of hypercoaguability and impaired fibrinolysis [14] , receptor for advanced glycation end-products (RAGE) [15] , vascular endothelial growth factor, and cell adhesion molecules [16] . In contrast, Hoffman and colleagues reported that proinflammatory cytokines in PGD cases decreased to very low levels after transplantation [17] . Other studies have added to a large number of possible molecular participants in IRI, and investigations are trying to validate these with accurate and informative results. Since the responses to ischemia and/or reperfusion occur rapidly and dramatically in cells through many signaling pathways, careful attention should be paid to the study design and possible organ-specific aspects of these responses.
To describe the precise mechanisms of IRI, the current study was limited by the lack of validation of the protein levels, intra-graft localization of IRI mediators, and lack of measurement of other important factors, such as MAP kinases. Further studies using knockout mice and protein assays are required to address these limitations.
Nevertheless, our present study indicates that, under the condition of prolonged hypothermic graft preservation, the induction of EGR1 and its downstream target genes, MIP-2 and PAI-1, may aggravate IRI following lung transplantation. This suggests that profound injury in clinical IRI might be distinguished by the upregulation of selected molecular pathways, which may be useful for the prediction or early detection of the severity of IRI. Furthermore, possible strategies to limit the upregulation of these IRIrelated genes after cold preservation of lung grafts might improve the clinical outcomes after lung transplantation.
